Correction (DOI:10.1016/j.jacc.2008.04.059);An ACE in the Hole. Alternative Pathways of the Renin Angiotensin System and Their Potential Role in Cardiac Remodeling**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 9, 2008, Pages 755-757

  Greenberg, Barry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ACE2; angiotensin; cardiac remodeling; heart failure; renin angiotensin system

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSIN[1-7]; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE;

CARDIOVASCULAR DISEASE; EDITORIAL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GENE EXPRESSION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 49349108634     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.016     Document Type: Erratum

References (19)

1. Dostal D.E., and Baker K. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?. Circ Res 85 (1999) 643-650
2. Francis G.S., Benedict C., Johnstone D.E., et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
3. Weber K.T. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 96 (1997) 4065-4082
4. Peng J., Gurantz D., Tran V., Cowling R.T., and Greenberg B.H. Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis. Circ Res 91 (2002) 1119-1126
5. Greenberg B., Quinones M.A., Koilpillai C., et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation 91 (1995) 2573-2581
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
7. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., and Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275 (2000) 33238-33243
8. Ishiyama Y., Gallagher P.E., Averill D.B., Tallant E.A., Brosnihan K.B., and Ferrario C.M. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43 (2004) 970-976
9. Santos R.A.S., Silva A.C.S.E., Maric C., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100 (2003) 8258-8263
10. Tallant E.A., Ferrario C.M., and Gallagher P.E. Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol Heart Circ Physiol 289 (2005) H1560-H1566
11. Iwata M., Cowling R.T., Gurantz D., et al. Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 289 (2005) H2356-H2363
12. Crackower M.A., Sarao R., Oudit G.Y., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417 (2002) 822-828
13. Grobe J.L., Mecca A.P., Lingis M., et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). Am J Physiol Heart Circ Physiol 292 (2006) H736-H742
14. Loot A.E., Roks A.J., Henning R.H., et al. Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105 (2002) 1548-1550
15. Burrell L.M., Risvanis J., Kubota E., et al. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 26 (2005) 369-375
16. Goulter A.B., Goddard M.J., Allen J.C., and Clark K.L. ACE2 gene expression is up-regulated in the human failing heart. BMC Med 2 (2004) 19
17. Epelman S., Tang W.H.W., Chen S.Y., Van Lente F., Francis G.S., and Sen S. Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J Am Coll Cardiol 52 (2008) 750-754
18. Lambert D.W., Yarski M., Warner F.J., et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 280 (2005) 30113-30119
19. Satoh M., Nakamura M., Saitoh H., et al. Tumor necrosis factor-alpha converting enzyme and tumor necrosis factor-alpha in human dilated cardiomyopathy. Circulation 99 (1999) 3260-3265